Nicotine Replacement Treatment for Pregnant Smokers - 1
NCT00115687 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 250
Last updated 2017-01-12
Summary
Smoking during pregnancy is an important modifiable cause of poor pregnancy outcomes. Even with augmented behavioral interventions, smoking cessation rates in pregnancy trials rarely exceed 20%. These low quit rates may be due to inadequate treatment of the physical dependence on nicotine. Indeed, medications, which may help to reduce nicotine withdrawal symptoms, are a first-line treatment for smoking treatment in non-pregnant smokers. However, little information is available on the safety or efficacy of medications to treat pregnant smokers.
The purpose of this trial is to evaluate the safety and effectiveness of 2 mg nicotine gum in promoting smoking cessation during pregnancy. The design is a randomized, placebo controlled trial where subjects are randomized to nicotine gum (6 weeks ad libitum use followed by a 6 week taper) or a matching placebo. Women who are doing well at the end of the trial will also be offered gum post-partum for relapse prevention.
Conditions
- Tobacco Use Disorder
Interventions
- DRUG
- DRUG
-
2 mg nicotine polacrilex
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Cheryl A Oncken, M.D. · UConn Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 16 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-06-30
- Primary Completion
- 2007-04-30
- Completion
- 2007-04-30
Countries
- United States
Study Locations
More Related Trials
-
Study to Determine the Efficacy and Safety of a Novel Nicotine Replacement Therapy
NCT02355665 ·Status: COMPLETED ·Phase: PHASE3
-
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
NCT06966362 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Study of Nicotine Replacement Therapy in Pregnancy
NCT00744913 ·Status: WITHDRAWN ·Phase: PHASE3
-
Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women
NCT04033237 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Oral Tobacco Products Compared to a Medicinal Nicotine
NCT00710034 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2
NCT00136838 ·Status: COMPLETED ·Phase: NA
-
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
NCT01075659 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
NCT01771627 ·Status: COMPLETED ·Phase: NA
-
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963 ·Status: COMPLETED ·Phase: NA
-
Bupropion for Smoking Cessation During Pregnancy
NCT01390246 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Medication as a Potential Smoking Cessation Aid
NCT02265367 ·Status: COMPLETED ·Phase: NA
-
Test of Novel Drug for Smoking Cessation
NCT02217527 ·Status: COMPLETED ·Phase: PHASE2
-
Use of Nicotine Pouches Among Daily Smokers
NCT06043362 ·Status: RECRUITING ·Phase: NA
-
Provoked Craving Assessment
NCT01506908 ·Status: COMPLETED ·Phase: PHASE2
-
Bupropion for Smoking Cessation in Pregnancy
NCT01875172 ·Status: COMPLETED ·Phase: PHASE2
-
Human Laboratory Study Of Varenicline in Smokers
NCT00709696 ·Status: COMPLETED ·Phase: NA
-
Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking
NCT00301145 ·Status: COMPLETED ·Phase: NA
-
To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers
NCT03543137 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Nicotine Lozenge in Relief of Provoked Acute Craving
NCT01466361 ·Status: COMPLETED ·Phase: PHASE2
-
Varenicline For Smokers In Recovery From Alcohol Dependence
NCT01092702 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Varenicline for the Treatment of Smokeless Tobacco
NCT00813917 ·Status: COMPLETED ·Phase: NA
-
Non-Nicotine Agents for Smoking Cessation
NCT00108537 ·Status: COMPLETED ·Phase: PHASE3
-
Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
NCT00365508 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility of Treatment for Vaping Cessation
NCT04317300 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Comparisons of Nicotine-free Cigarettes, Extra Low Nicotine Cigarettes vs. Medicinal Nicotine
NCT00777569 ·Status: COMPLETED ·Phase: PHASE2